Ginkgo Bioworks has announced the launch of its model API, a tool aimed at making biological AI models accessible to researchers, developers, and machine learning scientists. This API, developed in …
Sirtex Medical, a company known for developing treatments for liver cancer, has received EU certification for its SIR-Spheres Y-90 resin microspheres and launched its new SIROS Delivery System in Europe. …
Arctoris, a contract research organization (CRO) specializing in automated drug discovery, has acquired Eli Lilly's Life Sciences Studio laboratory. The acquisition involves relocating the lab's advanced automation platform from San …
In a recent WHO report, Director-General Dr. Tedros Ghebreyesus raised concerns about the global STI epidemic saying, “HIV, viral hepatitis, and sexually transmitted infections (STIs) continue to pose a major …
Genesis Therapeutics has partnered with Gilead Sciences in a strategic collaboration focusing on Genesis' GEMS (Genesis Exploration of Molecular Space) platform for drug discovery. Gilead will pay Genesis $35 million …
Roche has announced an expansion of its Digital Pathology Open Environment, integrating over 20 artificial intelligence (AI) algorithms from eight new collaborators into its navify® Digital Pathology platform. This move …
This week, Creation Healthcare launched a new platform that's set to change how the pharmaceutical industry finds and connects with key voices in healthcare. Called DOL Finder, the platform was …
Cellino Biotech, Inc. has been awarded up to $25 million by the Advanced Research Projects Agency for Health (ARPA-H), part of the U.S. Department of Health and Human Services, to …
Scientist.com has announced a partnership with Evotec SE, aimed at integrating Evotec’s advanced drug discovery and development services into Scientist.com’s online research platform. This collaboration will make Evotec’s comprehensive suite …
Relay Therapeutics has reported encouraging results from a small clinical trial of its experimental breast cancer drug, RLY-2608, which demonstrated a median progression-free survival of approximately nine months when combined …
BIOCAPTIVA, a biotech company based in Edinburgh, has been granted its first US patent for a liquid biopsy technology designed to efficiently capture cell-free DNA (cfDNA) directly from blood and …
MGI Tech Co., Ltd., a global developer of life science technologies, has launched two new nanopore sequencing products, CycloneSEQ-WT02 and CycloneSEQ-WY01, equipped with advanced CycloneSEQ technology. This new technology integrates …
We use cookies to personalise content and to analyse our traffic.
You consent to our cookies if you continue to use our website. Read more details in our
cookies policy.